SCHEMBL9570487

SCHEMBL9570487

CCC(C(=O)O)S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 8/20 0.52
MMP9 P14780 7/20 0.52
MMP13 P45452 4/20 0.49
MMP3 P08254 3/20 0.49
PHGDH O43175 1/20 0.45
ALDH1A1 P00352 4/20 0.43
SLC1A3 P43003 1/20 0.43
SLC1A2 P43004 1/20 0.43
SLC1A1 P43005 1/20 0.43
RECQL P46063 1/20 0.42
GAA P10253 2/20 0.42
MMP1 P03956 2/20 0.42
MMP7 P09237 1/20 0.42
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP8 P22894 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28043061 0.86 MMP2 (0.52) MMP2MMP9MMP13MMP3ALDH1A1
SCHEMBL28043062 0.86 MMP2 (0.52) MMP2MMP9MMP13MMP3ALDH1A1
SCHEMBL7772552 0.86 MMP2 (0.51) MMP2MMP9PHGDHCA1CA2
SCHEMBL1700880 0.85 MMP2 (0.50) MMP2MMP9MMP13MMP3MMP1
SCHEMBL29144731 0.84 ALDH1A1 (0.42) MMP2MMP9MMP13MMP3ALDH1A1
SCHEMBL26108918 0.84 ALDH1A1 (0.50) MMP2MMP9MMP13MMP3ALDH1A1
SCHEMBL18587741 0.84 MMP2 (0.51) MMP2MMP9MMP13MMP3ALDH1A1
SCHEMBL27911762 0.84 MMP2 (0.70) MMP2MMP9MMP13MMP3PHGDH
SCHEMBL8936409 0.84 MMP2 (0.51) MMP2MMP9MMP13MMP3ALDH1A1
Hydrochloric Acid SCHEMBL5120935 0.84 MMP2 (0.49) MMP2MMP9MMP13MMP3MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2026-04-30 US disclosed
EP-4593631-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME Mars, Incorporated (US) 2025-08-06 EP disclosed
WO-2024073025-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-04 WO disclosed
EP-4344552-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-03 EP disclosed
EP-3397736-A2 LOW VISCOSITY LOW VOLATILITY LUBRICATING OIL BASE STOCKS AND METHODS OF USE THEREOF ExxonMobil Research and Engineering Company (US) 2018-11-07 EP disclosed
WO-2017116895-A2 LOW VISCOSITY LOW VOLATILITY LUBRICATING OIL BASE STOCKS AND METHODS OF USE THEREOF EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2017-07-06 WO disclosed
EP-0537463-A2 Substituted pyrido(2,3-d)pyrimidines as antidotes BASF Aktiengesellschaft (DE) 1993-04-21 EP disclosed
US-4933367-A Carboxylic acid derivatives, processes for the preparation thereof, the use thereof, and pharmaceutical compositions which contain these compounds BOEHRINGER MANNHEIM GMBH (DE) 1990-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME PIGS, TAS2R13, CEL MMP2 2699/4885MMP9 2004/4885MMP13 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.